000 | 01723 a2200529 4500 | ||
---|---|---|---|
005 | 20250511014609.0 | ||
264 | 0 | _c19790917 | |
008 | 197909s 0 0 eng d | ||
022 | _a0095-4543 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFedson, D S | |
245 | 0 | 0 |
_aRecent developments in immunization. _h[electronic resource] |
260 |
_bPrimary care _cMar 1979 |
||
300 |
_a169-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDiphtheria Toxoid _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 |
_aHerpes Zoster _xprevention & control |
650 | 0 | 4 |
_aHerpesvirus 3, Human _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 |
_aImmunoglobulins _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aInfluenza Vaccines _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeasles Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMumps Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aPertussis Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aPneumococcal Infections _xprevention & control |
650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xtherapeutic use |
650 | 0 | 4 |
_aPoliovirus Vaccine, Oral _xtherapeutic use |
650 | 0 | 4 |
_aRabies Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aRubella Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aTetanus Toxoid _xtherapeutic use |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVaccines _xstandards |
773 | 0 |
_tPrimary care _gvol. 6 _gno. 1 _gp. 169-94 |
|
999 |
_c218606 _d218606 |